Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare aggressive malignant smooth muscle neoplasm, arising from the bone. It is characterized by a proliferation of neoplastic spindle cells.
Biomarker and diagnostic research for bone leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for bone leiomyosarcoma.
49 publications have been identified in PubMed for bone leiomyosarcoma. Research spans Case Report / Case Series (25%), Review / Meta-Analysis (19%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 25% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
9 |
19% |
Disease patterns and progression | 8 | 17% |
Testing and diagnosis research | 7 | 15% |
Clinical study results | 6 | 13% |
Laboratory research | 4 | 8% |
New treatment approaches | 2 | 4% |
Remiszewski P (2026). [PMID: 41513885](https://pubmed.ncbi.nlm.nih.gov/41513885/). *Cell Mol Life Sci*. [Review / Meta-Analysis]
Monga V (2026). [PMID: 41554272](https://pubmed.ncbi.nlm.nih.gov/41554272/). *Lancet Oncol*. [Clinical Trial Publication]
Wong CS (2026). [PMID: 42128474](https://pubmed.ncbi.nlm.nih.gov/42128474/). *Surg Oncol*. [Review / Meta-Analysis]
Diab T (2026). [PMID: 41562936](https://pubmed.ncbi.nlm.nih.gov/41562936/). *Med Sci (Basel)*. [Basic Science / Preclinical]
D'Ambrosio L (2026). [PMID: 41354211](https://pubmed.ncbi.nlm.nih.gov/41354211/). *Ann Oncol*. [Clinical Trial Publication]
Argyris PP (2025). [PMID: 40526340](https://pubmed.ncbi.nlm.nih.gov/40526340/). *Head Neck Pathol*. [Review / Meta-Analysis]
Sobczuk P (2025). [PMID: 39939795](https://pubmed.ncbi.nlm.nih.gov/39939795/). *Sci Rep*. [Diagnostic / Biomarker]
Quan P (2025). [PMID: 41201467](https://pubmed.ncbi.nlm.nih.gov/41201467/). *Int J Biol Markers*. [Review / Meta-Analysis]
Bellan E (2025). [PMID: 40626672](https://pubmed.ncbi.nlm.nih.gov/40626672/). *Pathologica*. [Basic Science / Preclinical]
Olvera-Valencia M (2025). [PMID: 40723917](https://pubmed.ncbi.nlm.nih.gov/40723917/). *Biomolecules*. [Gene Therapy / Novel Therapeutics]